In HCC, the loss of HNF4α disrupts epithelial identity and promotes epithelial-to-mesenchymal transition (EMT), a process that enhances cancer cell invasiveness, proliferation, chemoresistance, and metastatic potential. The gene discussed is HNF4A; the disease is cancer.